Isoliquiritigenin‐induced effects on Nrf2 mediated antioxidant defence in the HL‐60 cell monocytic differentiation
Hongmei Chen,Bo Zhang,Xuan Yuan,Ying Yao,Hong Zhao,Xiling Sun,Q. Zheng
DOI: https://doi.org/10.1002/cbin.10156
IF: 4.473
2013-11-01
Cell Biology International
Abstract:To evaluate the role of redox homeostasis in differentiation in human promyelocytic leukemia cells (HL‐60) induced by isoliquiritigenin (ISL) through modulation of the nuclear erythroid‐related factor 2/antioxidant responsive element (Nrf2/ARE) pathway. Morphological changes, cell surface markers CD11b/CD14, and nitroblue tetrazolium (NBT)‐reducing ability were used to determine the differentiation of HL‐60, and 2,7‐dichlorofluorescein was used to detect the level of intracellular reactive oxygen species (ROS). Thiobarbituric acid test was utilised to determine the levels of malondialdehyde production in ISL‐treated HL‐60. The study determines and presents the redox state of the ratio of reduced/oxidised glutathione as a consequence of progression from differentiation in HL‐60. Expression levels of the Nrf2/ARE downstream target genes were determined by quantitative polymerase chain reaction. Nicotinamide adenine dinucleotide phosphate‐oxidase (NADPH oxidase) inhibitors, apocynin (APO), and diphenyleneiodonium (DPI) were used for the preliminary study to determine the potential downstream targets regulated by NADPH oxidase in ISL‐induced HL‐60 differentiation. The data showed a strong dose–response relationship between ISL exposure and the characteristics of HL‐60 differentiation, namely, morphology changes, NBT reductive activities, and expression levels of surface antigens CD11b/CD14. Intercellular redox homeostasis changes toward oxidation during drug exposure are necessary to support ISL‐induced differentiation. The unique expression levels of the Nrf2/ARE downstream target genes in the differentiation of HL‐60 recorded a statistically significant and dose‐dependent increase (P < 0.05), which were suppressed by NADPH oxidase inhibitor, APO, and DPI. ISL as a differentiation‐inducing agent with mechanisms involved in the Nrf2/ARE pathway to modulate intercellular redox homeostasis, and thus, facilitate differentiation.